NEWS

For our visitors who seek the latest industry news and updates to keep up with the goings-on of the business on a global scale, this portal grants a dynamic and diverse feed of news items contemporaneous with the current affairs of the Pharmaceutical Industry.

news

Telix Pharmaceuticals Limited (“Telix”) is pleased to announce a product development partnership with Therapeia GmbH & Co KG (“Therapeia”). Telix will add Therapeia’s ACD-101 theranostic program for glioblastoma to its pipeline of advanced theranostic radiopharmaceutical products. Telix also has secured the option to acquire Therapeia under pre-agreed terms. The financial…

news

The U.S. Food and Drug Administration said on Thursday it had approved Synergy Pharmaceuticals Inc's drug to treat chronic idiopathic constipation (CIC). Synergy's once-daily tablet, Trulance, is the company's first to win regulatory clearance. However, the safety and effectiveness of the drug have not been established in patients less than…

news

Zydus Cadila, a leading global healthcare provider announced that it has acquired Sentynl Therapeutics Inc., a US based specialty pharma company specialized in marketing of products in the pain management segment. The transaction will be EPS accretive. With this acquisition, Zydus makes a foray into the specialty pain market in…

news

Mallinckrodt Plc has agreed to pay $100 million to settle allegations that a subsidiary broke U.S. antitrust law by sharply increasing the price of a multiple sclerosis drug while ensuring that no rival medicine appeared on the market, the Federal Trade Commission said on Wednesday. Mallinckrodt's share price dropped sharply…

news

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that its product candidate Resolaris™ was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of limb girdle muscular dystrophy 2B (LGMD2B),…

news

Evotec AG today announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, Tokyo, Japan. Under the terms of the agreement, Evotec will apply its integrated drug discovery platform including medicinal chemistry,…

news

The U.S. Food and Drug Administration said it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with narcolepsy, a kind of sleeping disorder. The approved generic is developed by Roxane Laboratories Inc, the FDA told Reuters. Jazz Pharma's shares, which lost about 22…

news

Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that the European Commission has granted Orphan Designation in the European Union ("EU") for the Company's novel synthetic oral endocannabinoid-mimetic drug, JBT-101 ("Resunab") for the treatment of systemic sclerosis. "We…

news

Biogen Inc said on Tuesday it would pay Forward Pharma A/S $1.25 billion to license the Danish company's patents covering multiple sclerosis drugs, providing Biogen an insurance policy on future sales of Tecfidera, its blockbuster oral treatment for the disease. Biogen and Forward Pharma have been locked in a dispute…

news

Jeil Pharmaceutical Co Ltd Says it will divest medicine production business into new subsidiary, named Pharmaceutical Co.,Ltd. Says the company will remain and change company name to Jeil Pharma Holdings Inc. Says it will be engaged in investment business and act as holding company after name change. Expected divestiture date…